Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9476928.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Somatostatin receptor expression, which was not a previously described marker for Hürthle cell cancer of the thyroid, was demonstrated by in vivo imaging with (111)In-pentetreotide in three patients. This phenomenon not only adds another imaging technique to the nuclear medicine armamentarium for detecting recurrent and metastatic cancer in patients with Hürthle cell cancer but also opens up an alternative therapeutic avenue with somatostatin analogs or their radiolabeled compounds.
Medical subject headings
- Adenoma, Oxyphilic
- Receptors, Somatostatin
- Thyroid Neoplasms